Irlande - anglais - HPRA (Health Products Regulatory Authority)

tillotts pharma limited - mesalazine - suppositories - 500 milligram

Arabie saoudite - anglais - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tillotts pharma gmbh, germany - mesalazine - modified-release tablet - 1600 mg

Israël - anglais - Ministry of Health

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.

Israël - anglais - Ministry of Health

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."

Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 400,0 mg

Afrique du Sud - anglais - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 800,0 mg

Arabie saoudite - anglais - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tillotts pharma gmbh, germany - fidaxomicin - film-coated tablet - 200 mg

Israël - anglais - Ministry of Health

tradis gat ltd - mesalazine - modified release tablets - mesalazine 1600 mg - mesalazine - asacol 1600 is indicated for:ulcerative colitis-for the treatment of mild to moderate acute disease-for the maintenance of remission

Israël - anglais - Ministry of Health

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - mesalazine, quantity: 800 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.